NCT03759678: An ongoing trial by IntraBio Inc
This trial is ongoing. It must report results 1 month, 3 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT03759678 |
|---|---|
| Title | Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T): A Multinational, Multicenter, Open-label, Rater-blinded Phase II Study |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 8, 2020 |
| Completion date | March 1, 2025 |
| Required reporting date | March 1, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 23, 2025 |
| Days late | None |